Ieramilimab
(Synonyms:埃拉利单抗)
目录号 : KM32067
CAS No. : 2137049-37-5
纯度 : 98%
Ieramilimab (LAG525; IMP701) 是一种人源化 IgG4 单克隆抗体,结合 LAG-3,从而抑制 LAG-3 与 MHC-II 分子的相互作用。Ieramilimab 通过减少 T 细胞耗竭、增强细胞因子输出和细胞毒性,恢复 T 细胞和 NK 细胞介导的抗白血病免疫。Ieramilimab 增加细胞毒性 T 淋巴细胞的浸润,并降低调节性 T 细胞 (Tregs) 和表达 ADAM10 的肿瘤细胞的基线密度。Ieramilimab 可用于研究多种恶性肿瘤,包括黑色素瘤、肾细胞癌和晚期实体瘤。
Other Forms of Rapamycin:
KKL Med 的所有产品和服务仅用于科学研究,不能被用于人体,兽医,我们也不向个人提供产品和服务。
KKL 顾客使用本产品发表的 0 篇科研文献
暂无科研文献
| 生物活性 |
Ieramilimab (LAG525; IMP701) is a humanized IgG4 monoclonal antibody that binds to LAG-3, resulting in inhibition of LAG-3 interaction with MHC-II molecules. Ieramilimab restores T-cell and NK-cell-mediated antileukemic immunity by reducing exhaustion and augmenting cytokine output and cytotoxicity. Ieramilimab increases the infiltration of cytotoxic T lymphocytes and reduces baseline densities of regulatory T cells (Tregs) and ADAM10-expressing tumor cells. Ieramilimab can be used for the study of various malignancies including melanoma, RCC, and advanced solid tumors.
|
| 分子量 |
146.78 kDa
|
| CAS号 |
2137049-37-5
|
| 中文名称 |
埃拉利单抗
|
| 运输条件 |
Shipping with dry ice.
|
| 储存方式 |
Store at -20˚C
|